The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score -7.20 — distress zone — historically elevated failure riskWatch
- Earnings-manipulation signal · Beneish M -3.23 — no flag raisedOK
- Earnings quality 58/100 — worth a closer lookWatch
Where the revenue comes from
Fiscal 2025, as PRECISION BIOSCIENCES INC reports it. History and quarterly detail are in the app.
- Operating$34.3M
Leadership changes
From PRECISION BIOSCIENCES INC's own filings, the day they're filed.
- Sam Wadsworth · director · departureeff. 2025-03-04
- Sam Wadsworth · Directors · departureeff. 2025-01-23
- Alan List · Chief Medical Officer · departureeff. 2024-09-13
Latest filings
- 8-K · Company announcement2026-05-27
- 8-K · Company announcement2026-05-26
- 8-K · Company announcement2026-05-05
- 10-Q · Quarterly report2026-05-05
- DEF 14A · Annual proxy (pay & governance)2026-04-08
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about PRECISION BIOSCIENCES INC, every answer cited🔒
- The Intelligence Brief — added when PRECISION BIOSCIENCES INC's brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.